These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12946603

  • 1. Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.
    Rünkorg K, Veraksits A, Kurrikoff K, Luuk H, Raud S, Abramov U, Matsui T, Bourin M, Kõks S, Vasar E.
    Behav Brain Res; 2003 Sep 15; 144(1-2):125-35. PubMed ID: 12946603
    [Abstract] [Full Text] [Related]

  • 2. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M, Zarrindast MR.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):78-87. PubMed ID: 18191832
    [Abstract] [Full Text] [Related]

  • 3. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S, Volke V, Veraksits A, Rünkorg K, Sillat T, Abramov U, Bourin M, Huotari M, Männistö PT, Matsui T, Vasar E.
    Psychopharmacology (Berl); 2001 Nov 17; 158(2):198-204. PubMed ID: 11702094
    [Abstract] [Full Text] [Related]

  • 4. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.
    Sora I, Elmer G, Funada M, Pieper J, Li XF, Hall FS, Uhl GR.
    Neuropsychopharmacology; 2001 Jul 17; 25(1):41-54. PubMed ID: 11377918
    [Abstract] [Full Text] [Related]

  • 5. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD, Matthes HW, Walwyn WM, Kieffer BL, Maidment NT.
    Neuroscience; 2001 Jul 17; 106(4):757-63. PubMed ID: 11682161
    [Abstract] [Full Text] [Related]

  • 6. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
    Rünkorg K, Värv S, Matsui T, Kõks S, Vasar E.
    Neurosci Lett; 2006 Oct 02; 406(1-2):17-22. PubMed ID: 16916582
    [Abstract] [Full Text] [Related]

  • 7. Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors.
    Veraksits A, Rünkorg K, Kurrikoff K, Raud S, Abramov U, Matsui T, Bourin M, Kõks S, Vasar E.
    Psychopharmacology (Berl); 2003 Mar 02; 166(2):168-75. PubMed ID: 12545332
    [Abstract] [Full Text] [Related]

  • 8. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.
    Pommier B, Beslot F, Simon A, Pophillat M, Matsui T, Dauge V, Roques BP, Noble F.
    J Neurosci; 2002 Mar 01; 22(5):2005-11. PubMed ID: 11880531
    [Abstract] [Full Text] [Related]

  • 9. Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.
    Raud S, Rünkorg K, Veraksits A, Reimets A, Nelovkov A, Abramov U, Matsui T, Bourin M, Volke V, Kõks S, Vasar E.
    Psychopharmacology (Berl); 2003 Aug 01; 168(4):417-25. PubMed ID: 12709779
    [Abstract] [Full Text] [Related]

  • 10. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A, Cippitelli A, Martín AB, Granado N, Ortiz O, Bezard E, Chen JF, Navarro M, Rodríguez de Fonseca F, Moratalla R.
    Psychopharmacology (Berl); 2006 Apr 01; 185(2):160-8. PubMed ID: 16470403
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.
    Wen D, Ma CL, Zhang YJ, Meng YX, Ni ZY, Li SJ, Cong B.
    BMC Neurosci; 2012 Jun 08; 13():63. PubMed ID: 22682150
    [Abstract] [Full Text] [Related]

  • 12. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S, Soosaar A, Võikar V, Bourin M, Vasar E.
    Neuropeptides; 1999 Feb 08; 33(1):63-9. PubMed ID: 10657473
    [Abstract] [Full Text] [Related]

  • 13. Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice.
    Sakoori K, Murphy NP.
    Neurosci Lett; 2008 Oct 03; 443(2):108-12. PubMed ID: 18662746
    [Abstract] [Full Text] [Related]

  • 14. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
    Sakoori K, Murphy NP.
    Psychopharmacology (Berl); 2004 Mar 03; 172(2):129-36. PubMed ID: 14624329
    [Abstract] [Full Text] [Related]

  • 15. Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test.
    Raud S, Innos J, Abramov U, Reimets A, Kõks S, Soosaar A, Matsui T, Vasar E.
    Psychopharmacology (Berl); 2005 Sep 03; 181(2):347-57. PubMed ID: 15830228
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
    Blokhina EA, Sukhotina IA, Bespalov AY.
    Eur J Pharmacol; 2000 Oct 13; 406(2):227-32. PubMed ID: 11020485
    [Abstract] [Full Text] [Related]

  • 17. Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice.
    Skoubis PD, Lam HA, Shoblock J, Narayanan S, Maidment NT.
    Eur J Neurosci; 2005 Mar 13; 21(5):1379-84. PubMed ID: 15813947
    [Abstract] [Full Text] [Related]

  • 18. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M, Timár J, Riba P, Friedmann T, Király KP, Gyarmati S, Al-Khrasani M, Fürst S.
    Brain Res Bull; 2011 Jan 15; 84(1):53-60. PubMed ID: 20934489
    [Abstract] [Full Text] [Related]

  • 19. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
    Mamiya T, Noda Y, Ren X, Nagai T, Takeshima H, Ukai M, Nabeshima T.
    J Neural Transm (Vienna); 2001 Jan 15; 108(12):1349-61. PubMed ID: 11810400
    [Abstract] [Full Text] [Related]

  • 20. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S, Suzuki T, Misawa M, Nagase H.
    Eur J Pharmacol; 1999 Feb 26; 368(1):9-16. PubMed ID: 10096764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.